What to know about Joe Biden's Cancer Moonshot
The big picture: Former President Obama, who appointed Biden to lead the drive a year on from his son Beau Biden's 2015 death from brain cancer, said after it was announced that his VP has an aggressive for of cancer that's spread to his bones: "Nobody has done more to find breakthrough treatments for cancer in all its forms than Joe."
State of play: The Obama White House announced Cancer Moonshot in 2016 "to eliminate cancer as we know it" and kickstarted the national program with $1 billion in research funding.
It became known as the Beau Biden Cancer Moonshot Initiative.
Biden relaunched Cancer Moonshot in 2022 with the goals of reducing the age-adjusted death rate from cancer by 50% over 25 years and "making a decade's worth of progress in cancer prevention, diagnosis, and treatment in five years," per a National Cancer Institute post.
Tens of millions in funding has gone toward cancer programs since then, including $150 million last year to develop technologies that the Biden White House said would help with tumor-removal surgeries.
Cancer Moonshot has "supported 250 research projects and more than 70 programs and consortia," according to a National Cancer Institute (NCI) post that was last updated in April.
What he's saying: "After Beau died, I literally visited every major cancer research facility in the world — seven of them around the world. I wanted to see what was possible, and I did," then-President Biden said last September, according to recorded remarks of his speech before world leaders and scientists to announce the Quad Cancer Moonshot in his home state of Delaware.
"They're making significant progress," Biden said after the Quad heads of state from the U.S., Australia, Japan and India committed to the drive. "And it's not just because it's personal — this —but it's because it's possible," he added.
"Our goal is to team up, end cancer around the world, and start — starting with cervical cancer. I know it may sound unrealistic, but it's not."
How it worked: "Funded through the 21st Century Cures Act, the Cancer Moonshot brought together patients, advocates, researchers, and clinicians dedicated to utilizing resources across the government, academia, and the private sector," per the NCI.
Using a panel of experts' broad recommendations as a guide, NCI said it "identified goals that would reflect this guidance and accelerate discovery, increase collaboration, and expand data sharing across the cancer community."
Among the accomplishments the NCI lists the Cancer Moonshot achieving are expanding prevention drives, developing "new enabling cancer technologies to characterize tumors and test therapies" and intensifying research into the leading causes of childhood cancers.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
USA Today
22 minutes ago
- USA Today
A tech bailout? Trump admin in talks about taking 10% stake in chipmaker Intel
An Intel deal would be one of the largest government interventions in private industry since the U.S. auto industry's bailout under President Obama. WASHINGTON ― The Trump administration is in talks for the federal government to take a 10% equity stake in the troubled chipmaker company Intel, White House officials confirmed. The discussions, which come as Intel has struggled to open manufacturing centers planned in the United States, would be one of the largest government interventions in the private industry since the bailout of the U.S. auto industry under former President Barack Obama. "It's a creative idea that has never been done before to ensure that we're both reassuring these critical supply chains while also gaining something of it for the American taxpayer," White House press secretary Karoline Leavitt told reporters at an Aug. 19 press briefing when asked about the government potentially acquiring stake in Intel. Leavitt said U.S. Commerce Secretary Howard Lutick is "ironing out the details." Any deal between the U.S. and Intel would likely require approval from the company's board of directors. During an interview earlier in the day on CNBC's "Squawk Box," Treasury Secretary Scott Bessent said the federal government would take an equity stake in Intel in exchange for billions in federal grants awarded to the company by the Biden administration. "The stake would be a conversion of the grants and maybe increase the investment into Intel to help stabilize the company for chip production here in the U.S.," Bessent said. Former President Joe Biden's Chips and Science Act, signed into law in 2022, included $39 billion in subsidies to boost U.S. semiconductor manufacturing. President Donald Trump has repeatedly attacked the incentives as giveaways. Bloomerg News, which first reported on the discussions, said a 10% stake in the chipmaker would be worth around $10.5 billion ‒ an amount that would nearly match the $10.9 billion in federal grants Intel has received for commercial and military production. The greatest beneficiary of the Biden law was Intel, which announced several projects with help from the incentives including a sprawling semiconductor facility outside Columbus, Ohio, that the company hoped would become "the largest semiconductor manufacturing site on the planet." The Ohio project has been marred by delays, however. Intel's first Ohio plant was originally set to open in 2025, but financial challenges forced the company to delay that opening to 2030 or 2031. Lutnick told CNBC that the U.S. wants a return on any "investment" in Intel. "We should get an equity stake for our money," the Commerce secretary said in a separate interview with the network. "Instead of just giving grants away." The Intel arrangment wouldn't be the first time Trump has secured U.S. stake of private companies during his second term. As part of a merger between Japanese-based Nippon Steel and U.S. Steel that Trump approved in June, Nippon granted his administration a "golden share" in the company. Contributing: Max Filby, Columbus Dispatch; Reuters Reach Joey Garrison on X @joeygarrison.
Epoch Times
24 minutes ago
- Epoch Times
Trump Admin Tosses Biden-Era Policy Paying College Students for Poll Work
The Department of Education said it has rescinded Biden-era directives that allowed the use of federal dollars to pay college students to work at polling places. In new guidance issued Tuesday, the department clarified that the Federal Work Study (FWS) program, which provides part-time jobs for students with financial need, does not cover any jobs involving 'partisan or nonpartisan political activity.'
Yahoo
an hour ago
- Yahoo
Public EV fast charging poised for ‘robust' growth: WoodMac
This story was originally published on Utility Dive. To receive daily news and insights, subscribe to our free daily Utility Dive newsletter. U.S. electric vehicle sales continue to grow and the charging market outlook remains strong despite federal policy headwinds, according to Wood Mackenzie. The sector is showing 'resilience despite challenges,' the firm said Tuesday in its EV charging infrastructure forecast. The U.S. public DC fast charger segment will grow at a 'robust' 14% compound annual rate through 2040, WoodMac said, to reach 475,000 ports and generate $3.3 billion in annual market value. Globally, WoodMac anticipates EV charging ports will increase at 12.3% annually from 2026 to 2040, reaching 206.6 million ports. 'As utilization in public charging increases and infrastructure efficiency improves, we expect the ratio of EVs to public chargers to increase from 7.5 battery electric vehicles per charger in 2025 to 14.2 in 2040,' Oliver McHugh, senior EV charging research analyst for Wood Mackenzie, said in a statement. U.S. federal policy was supportive of electric vehicles under President Joe Biden, who oversaw development of the $5 billion National Electric Vehicle Infrastructure formula program designed to build a public fast charger network. Biden also extended a $7,500 tax credit for EV purchases. These incentives, plus new tailpipe emissions that would force manufacturers to produce more electric models, were intended to help meet Biden's goal of having half of new vehicle sales be an EV by 2030. President Donald Trump has largely opposed the EV transition. The tax and policy bill he signed in July eliminates the EV purchase credit after September. The Trump administration has also moved to weaken or eliminate vehicle emissions standards, and it put the NEVI program on hold for six months, though it has recently been revived. The U.S. Department of Transportation on Aug. 11 issued new NEVI guidance, with changes to make the program more efficient. EV advocates cheered the 'greater flexibility' for states and 'regulatory certainty' around funding rollouts. The market is 'undoubtedly experiencing whiplash' as it shifts between the Biden and Trump administrations, Stan Cross, electric transportation director at the Southern Alliance for Clean Energy, wrote in a Monday blog post. 'Still, the data shows that the US and global EV markets continue to grow steadily, indicating there is likely sufficient market momentum at home and abroad to withstand America's political EV flip-flop,' Cross wrote. EVs reached over 10% market share in 2024, Cross noted, and in the first half of this year more than 600,000 have been sold. EV sales declined 1.4% in June, relative to May, but their market share increased 1.1%, he added. The decline reversed in July, according to Cox Automotive, a services and technology provider for the sector. The EV market 'gained strong momentum in July, with new and used EV sales rising sharply as consumers accelerated purchases ahead of the Inflation Reduction Act's tax credit expiration,' Cox said Friday. 'If you ask me what the state of the EV market is today, I will respond that it is solid despite the shaky political ground,' Cross wrote. 'Though the politics of the moment may slow it down, the EV transition can't be stopped.' Recommended Reading DOT relaunches EV charging fund with stripped-down guidance Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
